Global Protein Chip Market to Surge at a CAGR of ~7% by 2030 | DelveInsight
DelveInsight's Protein Chip Market Insights report provides the current and forecast market analysis, individual leading protein ...
Up 174% in 2024, Is It Too Late to Buy This Breakout Biotech Stock?
Real-time index price for S&P 500 Index (INX), along with buy or sell indicators, analysis, charts, historical performance, news and more ...
STAT10h
Pfizer’s activist troubles, gene therapy questions, RFK Jr.’s MAHA ambitions
STAT's Readout LOUD podcast discusses Pfizer's woes, explains RFK Jr.'s 'MAHA' campaign, and mulls the latest about the Novo ...
Study finds high costs, few benefits associated with GLP-1 weight loss drugs
New study questions benefits of GLP-1 drugs for weight loss, finding high costs with little long-term health benefit. Read ...
CTLT Stock Falls as Potential Hindrance to NVO Buyout Deal Increases
Catalent stock faces uncertainty as several pharma companies voice concern about potential limited competition following the ...
precisionmedicineonline14h
AvenCell Raises $112M in Series B Financing to Advance CAR T-Cell Pipeline
The firm will use to funds to validate its CD123-targeted CAR T-cell therapies in acute myeloid leukemia in clinical studies.
BioSpace15h
Why It’s OK to Talk About Catalent’s Pending Buyout by ‘Novo’
The group of like-named companies that include Novo Holdings and Novo Nordisk—the two tied to a multibillion-dollar buyout of Catalent currently under FTC review—ultimately send proceeds to the Novo ...